Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT05300282. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT04837859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT05723055. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003337. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT06300528. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
ClinicalTrials.gov study NCT04621604. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00004908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed
ClinicalTrials.gov study NCT05162976. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00026182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody
ClinicalTrials.gov study NCT00938041. IPD Sharing: YES. Countries: 0. Publications: 0.
Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function
ClinicalTrials.gov study NCT00118170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03974243. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Prospective Study on HIV-related Hodgkin Lymphoma
ClinicalTrials.gov study NCT01468740. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07283679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06734871. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07093411. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03580564. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT04756726. IPD Sharing: NO. Countries: 1. Publications: 0.
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05221385. IPD Sharing: NO. Countries: 1. Publications: 0.
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
ClinicalTrials.gov study NCT02856646. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.